Literature DB >> 10648410

Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage.

C Billard1, S Delaire, E Raffoux, A Bensussan, L Boumsell.   

Abstract

Human CD100, the first semaphorin identified in the immune system, is a transmembrane protein involved in T-cell activation. In the present study, we showed that activation of peripheral blood or tonsillar B lymphocytes induced the expression of CD100 in CD38(+)CD138(-) cell populations, including in CD148(+) subpopulations, thus expressing a memory B-cell-like phenotype. Using an in vitro enzymatic assay, we found that protein tyrosine phosphatase (PTP) activities were immunoprecipitated with CD100 in these cell populations, which were isolated by cell sorting, as well as in most B-cell lines representing various stages of B-cell differentiation. Immunodepletion and Western blotting experiments demonstrated that CD45 was the PTP associated with CD100 in cell lines displaying pre-B, activated B, and pre-plasma cell phenotypes. CD45 also accounted for PTP activity immunoprecipitated with CD100 in CD38(+)CD138(-) cells sorted after activation of peripheral blood or tonsillar B lymphocytes. In contrast, no CD100-CD45 association was observed in plasma cell lines corresponding to the terminal B-cell differentiation stage. CD148, the other transmembrane PTP known to be implicated in lymphocyte signaling pathways, was either only partly involved in the CD100-associated PTP activity or not expressed in plasma cell lines, indicating the association of CD100 with another main PTP. Our data show that CD100 is differentially expressed and can functionally associate with distinct PTPs in B cells depending on their activation and maturation state. They also provide evidence for a switch in the CD100-associated PTP at terminal stage of B-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648410

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Semaphorins as signals for cell repulsion and invasion.

Authors:  Yoshio Goshima; Takaaki Ito; Yukio Sasaki; Fumio Nakamura
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

3.  Semaphorin 6C expression in innervated and denervated skeletal muscle.

Authors:  Anna Svensson; Rolf Libelius; Sven Tågerud
Journal:  J Mol Histol       Date:  2007-06-29       Impact factor: 2.611

4.  SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.

Authors:  Lu Liu; Lin Yang; Xiaojun Liu; Menghan Liu; Jing Liu; Xuefeng Feng; Ziyuan Nie; Jianmin Luo
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

Review 5.  Roles of Sema4D and Plexin-B1 in tumor progression.

Authors:  Ewe Seng Ch'ng; Atsushi Kumanogoh
Journal:  Mol Cancer       Date:  2010-09-21       Impact factor: 27.401

Review 6.  Transmembrane semaphorins, forward and reverse signaling: have a look both ways.

Authors:  Chiara Battistini; Luca Tamagnone
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

Review 7.  Roles of semaphorins in the immune and hematopoietic system.

Authors:  Jong Dae Ji; Lionel B Ivashkiv
Journal:  Rheumatol Int       Date:  2009-01-13       Impact factor: 3.580

8.  Placental expression of CD100, CD72 and CD45 is dysregulated in human miscarriage.

Authors:  Teresa Lorenzi; Angelo Turi; Maria Lorenzi; Francesca Paolinelli; Francesca Mancioli; Lucia La Sala; Manrico Morroni; Pasquapina Ciarmela; Angelo Mantovani; Andrea Luigi Tranquilli; Mario Castellucci; Daniela Marzioni
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

9.  Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.

Authors:  Hua Zhou; Maricel G Kann; Emily K Mallory; Ying-Hua Yang; Amr Bugshan; Nada O Binmadi; John R Basile
Journal:  Neoplasia       Date:  2016-12-27       Impact factor: 5.715

10.  CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72.

Authors:  Sa'ar Mizrahi; Gal Markel; Angel Porgador; Yuri Bushkin; Ofer Mandelboim
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.